Marlborough

Since its founding 40 years ago this month, Marlborough-based Diamond Machining Technology has grown into a leader and innovator of hand tool and knife sharpeners.

Marlborough drug maker Sunovion Pharmaceuticals announced positive results Monday for dosing increases while using Latuda in treating people with schizophrenia.

Even though the company again lost money, placements of ReWalk Robotics' exoskeletons more than doubled in the second quarter while a German court declared the systems to be medically necessary and must be covered by insurance.

Oxford Immunotec posted a 34-percent gain in revenue for the second quarter and has adjusted up its guidance for the full year to up to $84.5 million in revenue.

A Quest Diagnostics facility in Marlborough will be the testing site for a partnership geared towards helping consumers learn more about their genetic ethnicity and origins.

Marlborough exoskelton developer ReWalk Robotics on Tuesday announced it has teamed with the Stanford University School of Medicine to perform a regulator-mandated post-market study of its products.

Boston Scientific continues to press forward with more than $2 billion in sales in the second quarter of the year, growing adjusted earnings year-over-year despite $618 million in litigation costs.

Avidia Bank has expanded its leadership team as it prepares for future growth, the $1.3-billion community bank announced this week.

Boston Scientific announced Wednesday its acquisition of chronic pain treatment firm Cosman Medical, as the Marlborough company keeps its eyes set on non-opioid treatments.

Marlborough-based Sunovion Pharmaceuticals will seek regulatory approval for a new, quick-acting treatment of chronic obstructive pulmonary disease, after a final human trial reported positive results.